Emergence of a new antibiotic resistance mechanism in India, Pakistan, and the UK: a molecular, biological, and epidemiological study
- PMID: 20705517
- PMCID: PMC2933358
- DOI: 10.1016/S1473-3099(10)70143-2
Emergence of a new antibiotic resistance mechanism in India, Pakistan, and the UK: a molecular, biological, and epidemiological study
Abstract
Background: Gram-negative Enterobacteriaceae with resistance to carbapenem conferred by New Delhi metallo-beta-lactamase 1 (NDM-1) are potentially a major global health problem. We investigated the prevalence of NDM-1, in multidrug-resistant Enterobacteriaceae in India, Pakistan, and the UK.
Methods: Enterobacteriaceae isolates were studied from two major centres in India--Chennai (south India), Haryana (north India)--and those referred to the UK's national reference laboratory. Antibiotic susceptibilities were assessed, and the presence of the carbapenem resistance gene bla(NDM-1) was established by PCR. Isolates were typed by pulsed-field gel electrophoresis of XbaI-restricted genomic DNA. Plasmids were analysed by S1 nuclease digestion and PCR typing. Case data for UK patients were reviewed for evidence of travel and recent admission to hospitals in India or Pakistan.
Findings: We identified 44 isolates with NDM-1 in Chennai, 26 in Haryana, 37 in the UK, and 73 in other sites in India and Pakistan. NDM-1 was mostly found among Escherichia coli (36) and Klebsiella pneumoniae (111), which were highly resistant to all antibiotics except to tigecycline and colistin. K pneumoniae isolates from Haryana were clonal but NDM-1 producers from the UK and Chennai were clonally diverse. Most isolates carried the NDM-1 gene on plasmids: those from UK and Chennai were readily transferable whereas those from Haryana were not conjugative. Many of the UK NDM-1 positive patients had travelled to India or Pakistan within the past year, or had links with these countries.
Interpretation: The potential of NDM-1 to be a worldwide public health problem is great, and co-ordinated international surveillance is needed.
Copyright (c) 2010 Elsevier Ltd. All rights reserved.
Figures





Comment in
-
New Delhi metallo-β-lactamase 1.Lancet Infect Dis. 2010 Nov;10(11):749-50; author reply 752-4. doi: 10.1016/S1473-3099(10)70239-5. Lancet Infect Dis. 2010. PMID: 21029984 No abstract available.
-
New Delhi metallo-β-lactamase 1.Lancet Infect Dis. 2010 Nov;10(11):749; author reply 752-4. doi: 10.1016/S1473-3099(10)70238-3. Lancet Infect Dis. 2010. PMID: 21029985 No abstract available.
-
New Delhi metallo-β-lactamase 1.Lancet Infect Dis. 2010 Nov;10(11):750-1; author reply 752-4. doi: 10.1016/S1473-3099(10)70241-3. Lancet Infect Dis. 2010. PMID: 21029986 No abstract available.
-
New Delhi metallo-β-lactamase 1.Lancet Infect Dis. 2010 Nov;10(11):750; author reply 752-4. doi: 10.1016/S1473-3099(10)70240-1. Lancet Infect Dis. 2010. PMID: 21029987 No abstract available.
-
New Delhi metallo-β-lactamase 1.Lancet Infect Dis. 2010 Nov;10(11):751; author reply 752-4. doi: 10.1016/S1473-3099(10)70242-5. Lancet Infect Dis. 2010. PMID: 21029988 No abstract available.
-
New Delhi metallo-β-lactamase 1.Lancet Infect Dis. 2010 Nov;10(11):751-2; author reply 752-4. doi: 10.1016/S1473-3099(10)70243-7. Lancet Infect Dis. 2010. PMID: 21029989 No abstract available.
-
New Delhi metallo-β-lactamase 1.Lancet Infect Dis. 2010 Nov;10(11):752; author reply 752-4. doi: 10.1016/S1473-3099(10)70244-9. Lancet Infect Dis. 2010. PMID: 21029991 No abstract available.
-
Generic antibiotics, antibiotic resistance, and drug licensing.Lancet Infect Dis. 2010 Nov;10(11):754. doi: 10.1016/S1473-3099(10)70246-2. Lancet Infect Dis. 2010. PMID: 21029992 No abstract available.
-
Global spread of New Delhi metallo-β-lactamase 1.Lancet Infect Dis. 2010 Dec;10(12):828-9. doi: 10.1016/S1473-3099(10)70275-9. Lancet Infect Dis. 2010. PMID: 21109167 No abstract available.
-
Global spread of New Delhi metallo-β-lactamase 1.Lancet Infect Dis. 2010 Dec;10(12):828. doi: 10.1016/S1473-3099(10)70274-7. Lancet Infect Dis. 2010. PMID: 21109168 No abstract available.
-
Global spread of New Delhi metallo-β-lactamase 1.Lancet Infect Dis. 2010 Dec;10(12):829-30. doi: 10.1016/S1473-3099(10)70276-0. Lancet Infect Dis. 2010. PMID: 21109169 No abstract available.
-
Global spread of New Delhi metallo-β-lactamase 1.Lancet Infect Dis. 2010 Dec;10(12):830-1. doi: 10.1016/S1473-3099(10)70277-2. Lancet Infect Dis. 2010. PMID: 21109170 No abstract available.
-
Global spread of New Delhi metallo-β-lactamase 1.Lancet Infect Dis. 2010 Dec;10(12):831-2. doi: 10.1016/S1473-3099(10)70278-4. Lancet Infect Dis. 2010. PMID: 21109171 No abstract available.
-
Global spread of New Delhi metallo-β-lactamase 1.Lancet Infect Dis. 2010 Dec;10(12):832. doi: 10.1016/S1473-3099(10)70279-6. Lancet Infect Dis. 2010. PMID: 21109172 No abstract available.
-
NDM-1: a local clone emerges with worldwide aspirations.Future Microbiol. 2011 Feb;6(2):137-41. doi: 10.2217/fmb.10.171. Future Microbiol. 2011. PMID: 21366414
-
Balkan NDM-1: escape or transplant?Lancet Infect Dis. 2011 Mar;11(3):164. doi: 10.1016/S1473-3099(11)70048-2. Lancet Infect Dis. 2011. PMID: 21371654 No abstract available.
-
Balkan NDM-1: escape or transplant?Lancet Infect Dis. 2011 Aug;11(8):586. doi: 10.1016/S1473-3099(11)70202-X. Lancet Infect Dis. 2011. PMID: 21798461 No abstract available.
-
Urgent need for formal medical training in infectious diseases in India.Lancet Infect Dis. 2011 Nov;11(11):809-10. doi: 10.1016/S1473-3099(11)70300-0. Lancet Infect Dis. 2011. PMID: 22035612 No abstract available.
References
-
- Cornaglia G. Fighting infections due to multidrug-resistant Gram-positive pathogens. Clin Microbiol Infect. 2009;15:209–211. - PubMed
-
- Tan TT. “Future” threat of Gram-negative resistance in Singapore. Ann Acad Med Singapore. 2008;37:884–890. - PubMed
-
- Baiden F, Owusu-Agyei S, Webster J, Chandramohan D. The need for new antibiotics. Lancet. 2010;375:637–638. - PubMed
-
- Heddini A, Cars O, Qiang S, Tomson G. Antibiotic resistance in China—a major future challenge. Lancet. 2009;373:30. - PubMed
-
- Vento S, Cainelli F. The need for new antibiotics. Lancet. 2010;375:637. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous